Pharmacist Contributions as Members of the Multidisciplinary ICU Team

被引:84
|
作者
Preslaski, Candice R. [1 ]
Lat, Ishaq [4 ]
MacLaren, Robert [2 ]
Poston, Jason [3 ]
机构
[1] Denver Hlth Med Ctr, Dept Inpatient Pharm, Denver, CO USA
[2] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Clin Pharm, Aurora, CO USA
[3] Univ Chicago, Pritzker Sch Med, Dept Med, Sect Pulm Crit Care Med, Chicago, IL 60637 USA
[4] Univ Chicago, Med Ctr, Dept Pharm, Chicago, IL 60637 USA
关键词
INTENSIVE-CARE-UNIT; CRITICALLY-ILL PATIENTS; ECONOMIC OUTCOMES; MEDICATION ERRORS; MANAGED AMINOGLYCOSIDE; CLINICAL PHARMACISTS; PATIENT HARM; SERVICES; SEDATION; IMPACT;
D O I
10.1378/chest.12-1615
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Critical care pharmacy services in the ICU have expanded from traditional dispensing responsibilities to being recognized as an essential component of multidisciplinary care for critically ill patients. Augmented by technology and resource utilization, this shift in roles has allowed pharmacists to provide valuable services in the form of assisting physicians and clinicians with pharmacotherapy decision-making, reducing medication errors, and improving medication safety systems to optimize patient outcomes. Documented improvements in the management of infections, anticoagulation therapy, sedation, and analgesia for patients receiving mechanical ventilation and in emergency response help to justify the need for clinical pharmacy services for critically ill patients. Contributions to quality improvement initiatives, scholarly and research activities, and the education and training of interdisciplinary personnel are also valued services offered by clinical pharmacists. Partnering with physician and nursing champions can garner support from hospital administrators for the addition of clinical pharmacy critical care services. The addition of a pharmacist to an interprofessional critical care team should be encouraged as health-care systems focus on improving the quality and efficiency of care delivered to improve patient outcomes.
引用
收藏
页码:1687 / 1695
页数:9
相关论文
共 50 条
  • [31] Multidisciplinary team meetings in urogynaecology
    Gopinath, Deepa
    Jha, Swati
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2015, 26 (08) : 1221 - 1227
  • [32] Interdisciplinary Care Team with Pharmacist in a Community-based HIV Clinic
    Samuel, Oh
    Unonu, Jacqueise M.
    Dotson, Kierra
    Park, Soon
    Parker, Richard
    Wutoh, Anthony K.
    Lee, Euni
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2018, 110 (04) : 378 - 383
  • [33] Defining International Critical Care Pharmacist Contributions to Sepsis and Exploring Variability
    Oakley, Robert
    Al-Mahdi, Sarraa
    Guntschnig, Sonja
    Trinh, Ha
    Custodio, Marco
    Korshid, Sarah
    Gous, Andries
    Lonsdale, Dagan O.
    CURRENT INFECTIOUS DISEASE REPORTS, 2024, 26 (01) : 15 - 29
  • [34] Pharmacist Leadership in ICU Quality Improvement: Coordinating Spontaneous Awakening and Breathing Trials
    Stollings, Joanna L.
    Foss, Julie J.
    Ely, E. Wesley
    Ambrose, Anna M.
    Rice, Todd W.
    Girard, Timothy D.
    Wheeler, Arthur P.
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (08) : 883 - 891
  • [35] The Pharmacist as Part of the Primary Care Team During the COVID-19 Pandemic
    Moreau, Cynthia
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2021, 34 : S21 - S25
  • [36] The Multidisciplinary Team in the Treatment of Patients With Epilepsy
    Stern, John
    Stanton, Susan
    Howe-Martin, Laura
    Lane, Chadrick
    Sports, Christine
    Gidal, Barry
    Soby, Meghann
    Das, Rohit R.
    EPILEPSY CURRENTS, 2024,
  • [37] What is a virtual multidisciplinary team (vMDT)?
    Munro, A. J.
    Swartzman, S.
    BRITISH JOURNAL OF CANCER, 2013, 108 (12) : 2433 - 2441
  • [38] A scoping review of clinical pharmacist and pharmacy technician contributions to cystic fibrosis care
    Kim, Alexander S.
    Thompson, Amy N.
    Axon, David R.
    Sabourin, Ashley
    Davies, Madeleine J.
    Shannon, Carol
    Nasr, Samya Z.
    Phan, Hanna
    JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2023, 6 (12): : 1357 - 1365
  • [39] Impact of clinical pharmacist on cost of drug therapy in the ICU
    Aljbouri, Tareq M.
    Alkhawaldeh, Mohammed S.
    Abu-Rumman, Ala'a Eddeen K.
    Hasan, Thamer A.
    Khattar, Hakeem M.
    Abu-Oliem, Atallah S.
    SAUDI PHARMACEUTICAL JOURNAL, 2013, 21 (04) : 371 - 374
  • [40] Pharmacist-driven discontinuation of antipsychotics for ICU delirium: A quasi-experimental study
    Stuart, Misa M.
    Smith, Zachary R.
    Payter, Katelyn A.
    Martz, Carolyn R.
    To, Long
    Swiderek, Jennifer L.
    Coba, Victor E.
    Peters, Michael A.
    JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2020, 3 (06): : 1009 - 1014